Pharmaceutical intermediates
Indacaterol Maleate Intermediates
3 pharmaceutical intermediates for Indacaterol Maleate. Indication: Pulmonary Disease, Chronic Obstructive.
About Indacaterol Maleate
- Originator
- Novartis Pharmaceuticals Corp
- Indication
- Pulmonary Disease, Chronic Obstructive
- Approved Date
- 10/29/2015
- DS/DP
- 02/25/2025
Available intermediates
3 intermediates currently listed for Indacaterol Maleate. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | 312753-53-0 | / | / |
| 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline | 100331-89-3 | / | / |
| 5-ACETYL-8-HYDROXY-1H-QUINOLIN-2-ONE | 62978-73-8 | / | / |
Building toward Indacaterol Maleate?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →